Keros Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
LACHEY JENNIFER officer: Chief Scientific Officer
Common Stock 5,300 $64.73 $343,053
Option
LACHEY JENNIFER officer: Chief Scientific Officer
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Option
ORDONEZ CLAUDIA officer: Chief Medical Officer
Common Stock 1,000 $0.48 $480
Sale
ORDONEZ CLAUDIA officer: Chief Medical Officer
Common Stock 1,000 $64.48 $64,475
Option
ORDONEZ CLAUDIA officer: Chief Medical Officer
Employee Stock Option (right to buy) 1,000 $0.48 $480
Sale
KNOWLES JULIUS director
Common Stock 11,632 $28.67 $333,443
Sale
KNOWLES JULIUS director
Common Stock 11,632 $56.17 $653,369
Sale
KNOWLES JULIUS director
Common Stock 11,632 $56.17 $653,369
Sale
KNOWLES JULIUS director
Common Stock 12,327 $28.93 $356,645
Sale
KNOWLES JULIUS director
Common Stock 12,327 $57.38 $707,360
Sale
KNOWLES JULIUS director
Common Stock 10,711 $59.88 $641,353
Sale
KNOWLES JULIUS director
Common Stock 12,979 $23.44 $304,254
Sale
KNOWLES JULIUS director
Common Stock 12,979 $64.24 $833,758
Option
LACHEY JENNIFER officer: Chief Scientific Officer
Common Stock 33,200 $0.11 $3,652
Option
LACHEY JENNIFER officer: Chief Scientific Officer
Employee Stock Option (right to buy) 33,200 $0.11 $3,652
Sale
KNOWLES JULIUS director
Common Stock 2,944 $62.79 $184,860
Sale
KNOWLES JULIUS director
Common Stock 16,061 $60.78 $976,123
Sale
KNOWLES JULIUS director
Common Stock 16,061 $60.78 $976,123
Sale
KNOWLES JULIUS director
Common Stock 9,612 $37.71 $362,420
Sale
KNOWLES JULIUS director
Common Stock 7,468 $62.15 $464,121
Sale
KNOWLES JULIUS director
Common Stock 7,468 N/A N/A
Option
LACHEY JENNIFER officer: Chief Scientific Officer
Common Stock 5,300 $0.3 $1,590
Sale
LACHEY JENNIFER officer: Chief Scientific Officer
Common Stock 5,300 $65.44 $346,806
Option
LACHEY JENNIFER officer: Chief Scientific Officer
Employee Stock Option (right to buy) 5,300 $0.3 $1,590
Option
ORDONEZ CLAUDIA officer: Chief Medical Officer
Common Stock 1,000 $0.48 $480
Sale
ORDONEZ CLAUDIA officer: Chief Medical Officer
Common Stock 1,000 $65.37 $65,372
Sale
KNOWLES JULIUS director
Common Stock 6,958 N/A N/A
Option
ORDONEZ CLAUDIA officer: Chief Medical Officer
Employee Stock Option (right to buy) 1,000 N/A N/A
Purchase
PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. 10 percent owner
Common Stock 60,000 $50 $3,000,000
Purchase
NUSSBAUM RAN director, 10 percent owner
Common Stock 60,000 $50 $3,000,000
Purchase
KARIV TOMER director, 10 percent owner
Common Stock 60,000 $50 $3,000,000
Purchase
PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
GORDON CARL L director
Common Stock 375,200 $16 $6,003,200
Purchase
ORBIMED ADVISORS LLC director
Common Stock 375,200 $16 $6,003,200
Purchase
LAZARUS ALON director, 10 percent owner
Common Stock 120,000 $16 $1,920,000
Purchase
NUSSBAUM RAN director, 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
KARIV TOMER director, 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
SEEHRA JASBIR director, officer: Chief Execut..
Common Stock 20,000 $16 $320,000
Purchase
ARKIN BIO VENTURES LIMITED PARTNERSHIP 10 percent owner
Common Stock 120,000 $16 $1,920,000
Purchase
NUSSBAUM RAN director, 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
NUSSBAUM RAN director, 10 percent owner
Common Stock 437,499 $16 $6,999,984
Purchase
KARIV TOMER director, 10 percent owner
Common Stock 437,499 $16 $6,999,984

Showing 150 to 194 of 194 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.